Analyst firms · Citizens JMP · SBRA
Citizens JMP SBRA price target and rating history
Sabra Health Care REIT Inc. (SBRA) · Real Estate
Citizens JMP rates Sabra Health Care REIT Inc. (SBRA) Mkt Outperform with a $20 price target, as of its latest action on Jan 7, 2025. It has published 3 rating actions on SBRA since September 2021, including 1 upgrade and 1 downgrade. Across 3 firms with a SBRA price target in the last 12 months, the median target is $21.
- Current rating
- Mkt Outperform
- Price target
- $20
- Median target, all firms
- $21
- Actions on SBRA
- 3
Citizens JMP price target on SBRA
Every Citizens JMP rating on SBRA
- Jan 7, 2025
- Dec 13, 2022
- Sep 13, 2021
How other firms rate SBRA
Each firm's latest rating and stated target in the last 12 months.
| Firm | Rating | Price target | Date |
|---|---|---|---|
| Huntington | Outperform | $23 | Sep 10, 2026 |
| Raymond James | Mkt Perform | Aug 6, 2026 | |
| Truist Securities | Hold | Jul 8, 2026 | |
| Barclays | Overweight | $21 | Jul 7, 2026 |
| Citigroup | Neutral | $19 | Jun 23, 2026 |
Questions about Citizens JMP and SBRA
- What is Citizens JMP's price target for SBRA?
- Citizens JMP's latest stated price target for Sabra Health Care REIT Inc. (SBRA) is $20, from its action on Jan 7, 2025.
- What is Citizens JMP's rating on SBRA?
- Citizens JMP rates SBRA Mkt Outperform, a bullish rating, as of Jan 7, 2025.
- When did Citizens JMP last change its view on SBRA?
- On Jan 7, 2025, Citizens JMP upgrades to Mkt Outperform from Mkt Perform, price target $20.
- How does Citizens JMP's SBRA target compare with other analysts?
- Across 3 firms with a SBRA price target in the last 12 months, the median target is $21.
More SBRA rating histories
All Citizens JMP ratingsSBRA news and filingsEvery analyst firm
From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.